» Articles » PMID: 30261071

Inactivation of Human and Avian Influenza Viruses by Potassium Oleate of Natural Soap Component Through Exothermic Interaction

Overview
Journal PLoS One
Date 2018 Sep 28
PMID 30261071
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

An influenza epidemic is still a problem despite the development of vaccines and anti-influenza drugs. Preventive measures such as handwashing are fundamental and important for counteracting influenza virus infection. In this study, we clarified the anti-influenza virus effects of surfactants, which are the main components of hand soaps for hand washing: potassium oleate (C18:1), sodium laureth sulfate (LES) and sodium lauryl sulfate (SDS). For a human influenza virus strain (H3N2), C18:1 reduced the infectivity by 4 logs or more, whereas LES and SDS reduced the infectivity by 1 log or less. Similar results were obtained when an avian influenza virus strain (H5N3) was used. The interaction between the surfactant and virus was then investigated by isothermal titration calorimetry. The LES-virus system showed a positive value of enthalpy changes (ΔH), meaning an exothermic interaction that indicated a hydrophobic interaction. In contrast, both the C18:1-virus system and the SDS-virus system showed negative values of ΔH, meaning an endothermic interaction that indicated an electrical interaction. The ΔH value of the C18:1-virus system was much higher than that of the SDS-virus system. A mixture of C18:1 and HA proteins similarly showed negative values of ΔH. These results indicate that influenza virus inactivation by a hydrophobic interaction of a surfactant with the viral envelope is insufficient to prevent infection, whereas inactivation by an electrical interaction of a surfactant with HA proteins is sufficient to prevent influenza virus infection.

Citing Articles

Tethered Bilayer Lipid Membrane Platform for Screening Triton X-100 Detergent Replacements by Electrochemical Impedance Spectroscopy.

Tan S, Gooran N, Lim H, Yoon B, Jackman J Nanomaterials (Basel). 2023; 13(5).

PMID: 36903751 PMC: 10005542. DOI: 10.3390/nano13050874.


Development of a Propidium Monoazide-Based Viability Quantitative PCR Assay for Red Sea Bream Iridovirus Detection.

Kim K, Kang G, Woo W, Sohn M, Son H, Park C Int J Mol Sci. 2023; 24(4).

PMID: 36834834 PMC: 9958570. DOI: 10.3390/ijms24043426.


The SARS-CoV-2 Hydra, a tiny monster from the 21st century: Thermodynamics of the BA.5.2 and BF.7 variants.

Popovic M Microb Risk Anal. 2023; 23:100249.

PMID: 36777924 PMC: 9898946. DOI: 10.1016/j.mran.2023.100249.


Biothermodynamics of Viruses from Absolute Zero (1950) to Virothermodynamics (2022).

Popovic M Vaccines (Basel). 2022; 10(12).

PMID: 36560522 PMC: 9784531. DOI: 10.3390/vaccines10122112.


Complex formation of potassium salt of highly fatty acid with hemagglutinin protein in influenza virus via exothermic interaction.

Kawahara T, Sakou M, Fumotogawa Y, Kanazawa S, Sakaguchi T, Akiba I Biochem Biophys Rep. 2022; 31:101302.

PMID: 35782784 PMC: 9240363. DOI: 10.1016/j.bbrep.2022.101302.


References
1.
Ueda K, Kawabata R, Irie T, Nakai Y, Tohya Y, Sakaguchi T . Inactivation of pathogenic viruses by plant-derived tannins: strong effects of extracts from persimmon (Diospyros kaki) on a broad range of viruses. PLoS One. 2013; 8(1):e55343. PMC: 3555825. DOI: 10.1371/journal.pone.0055343. View

2.
Noma K, Kiyotani K, Kouchi H, Fujii Y, Egi Y, Tanaka K . Endogenous protease-dependent replication of human influenza viruses in two MDCK cell lines. Arch Virol. 1998; 143(10):1893-909. DOI: 10.1007/s007050050428. View

3.
Beigel J, Farrar J, Han A, Hayden F, Hyer R, de Jong M . Avian influenza A (H5N1) infection in humans. N Engl J Med. 2005; 353(13):1374-85. DOI: 10.1056/NEJMra052211. View

4.
Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W . Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med. 2013; 368(20):1888-97. DOI: 10.1056/NEJMoa1304459. View

5.
Ampofo K, Gesteland P, Bender J, Mills M, Daly J, Samore M . Epidemiology, complications, and cost of hospitalization in children with laboratory-confirmed influenza infection. Pediatrics. 2006; 118(6):2409-17. DOI: 10.1542/peds.2006-1475. View